v3.24.0.1
Earnings Per Share (Tables)
 12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Schedule of basic and diluted earnings per share, impact of two-class method
The following table summarizes the impact of the two-class method:
Years ended December 31,
(in millions, except per share data)202320222021
Basic EPS
Net earnings attributable to AbbVie Inc.$4,863 $11,836 $11,542 
Earnings allocated to participating securities43 54 74 
Earnings available to common shareholders$4,820 $11,782 $11,468 
Weighted average basic shares of common stock outstanding1,768 1,771 1,770 
Basic earnings per share attributable to AbbVie Inc.$2.73 $6.65 $6.48 
Diluted EPS
Net earnings attributable to AbbVie Inc.$4,863 $11,836 $11,542 
Earnings allocated to participating securities43 54 74 
Earnings available to common shareholders$4,820 $11,782 $11,468 
Weighted average shares of common stock outstanding1,768 1,771 1,770 
Effect of dilutive securities5 7 7 
Weighted average diluted shares of common stock outstanding1,773 1,778 1,777 
Diluted earnings per share attributable to AbbVie Inc.$2.72 $6.63 $6.45